BCL6 and post-transplant lymphoproliferative disease: A third group of PTLD is reminiscent of post-GC and pre-terminally differentiated B-cells and show the BCL6−/MUM1+/CD138+ phenotype and, if EBV positive, express the LMP1 antigen 21.